These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 18455698

  • 1. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection.
    Hanouneh IA, Feldstein AE, Lopez R, Yerian L, Pillai A, Zein CO, Zein NN.
    Clin Gastroenterol Hepatol; 2008 May; 6(5):584-9. PubMed ID: 18455698
    [Abstract] [Full Text] [Related]

  • 2. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S, Cammà C, Di Marco V, Cabibi D, Ciminnisi S, Caldarella R, Licata A, Massenti MF, Marchesini G, Craxì A.
    Antivir Ther; 2009 May; 14(5):631-9. PubMed ID: 19704165
    [Abstract] [Full Text] [Related]

  • 3. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, Colloredo G, Adinolfi LE, Asselah T, Jonsson JR, Smedile A, Terrault N, Pazienza V, Giordani MT, Giostra E, Sonzogni A, Ruggiero G, Marcellin P, Powell EE, George J, Negro F, HCV Meta-Analysis (on) Individual Patients' Data Study Group.
    Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
    Poustchi H, Negro F, Hui J, Cua IH, Brandt LR, Kench JG, George J.
    J Hepatol; 2008 Jan; 48(1):28-34. PubMed ID: 17977612
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS.
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [Abstract] [Full Text] [Related]

  • 6. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
    Patton HM, Patel K, Behling C, Bylund D, Blatt LM, Vallée M, Heaton S, Conrad A, Pockros PJ, McHutchison JG.
    J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
    [Abstract] [Full Text] [Related]

  • 7. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M, Mikuni M, Matsumura H, Nakamura H, Oshiro S, Aoki H, Shimizu T, Yamagami H, Shioda A, Kaneko M, Tanaka N, Arakawa Y.
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [Abstract] [Full Text] [Related]

  • 8. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
    Liu CJ, Jeng YM, Chen PJ, Lai MY, Yang HC, Huang WL, Kao JH, Chen DS.
    Antivir Ther; 2005 Apr; 10(3):405-15. PubMed ID: 15918331
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P.
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [Abstract] [Full Text] [Related]

  • 11. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
    Saadoun D, Asselah T, Resche-Rigon M, Charlotte F, Bedossa P, Valla D, Piette JC, Marcellin P, Cacoub P.
    Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
    [Abstract] [Full Text] [Related]

  • 12. Steatosis in hepatitis C virus infection. Response to anti-viral therapy.
    Szanto P, Grigorescu M, Dumitru I, Serban A.
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):117-24. PubMed ID: 16802005
    [Abstract] [Full Text] [Related]

  • 13. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S, Cammà C, Di Marco V, Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F, Tarantino G, Marchesini G, Craxì A.
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [Abstract] [Full Text] [Related]

  • 14. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA, Feldstein AE, McCullough AJ, Miller C, Aucejo F, Yerian L, Lopez R, Zein NN.
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
    Lemos LB, Perez RM, Lemos MM, Draibe SA, Silva IS, Silva AE, Ferraz ML.
    Nephron Clin Pract; 2008 Sep; 108(2):c135-40. PubMed ID: 18230916
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
    Murcia J, Portilla J, Bedia M, Palazón JM, Sánchez-Payá J, Saiz de la Hoya P, Payá A, Boix V, Merino E, Reus S.
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
    [Abstract] [Full Text] [Related]

  • 20. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C, Federico A, Masarone M, Torella R, Blanco Cdel V, Persico M.
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.